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First intramolecular Diels–Alder reactions using
chromone derivatives: synthesis of chromeno-
[3,4-b]xanthones and 2-(benzo[c]chromenyl)-
chromones†
Hélio M. T. Albuquerque, a Clementina M. M. Santos, ab José A. S. Cavaleiro a
and Artur M. S. Silva *a
A series of novel (E)-2-(2-propargyloxystyryl)chromones and (E,E)-2-[4-(2-propargyloxyphenyl)buta-1,3-
dien-1-yl]chromones were designed and synthesized via aldol condensation of 2-methylchromones with
2-propargyloxy(benzaldehyde and cinnamaldehyde), respectively. Both chromone derivatives were used
as substrates in microwave-assisted intramolecular Diels–Alder reactions, affording chromeno[3,4-b]-
xanthones and 2-(benzo[c]chromenyl)chromones. This is the first report involving chromone derivatives
in intramolecular Diels–Alder reactions for the synthesis of new oxygen heterocycles, namely xanthone-
and flavone-type compounds.
Introduction
Chromone (or 4H-chromen-4-one), a natural occurring 6-O-
membered heterocycle, is widely found as the basic core in a
large variety of compounds that exhibits important biological
properties.1,2 This ring system is also a useful substrate for
further functionalization, which can be achieved through oxidation,
condensation, conjugate addition or Diels–Alder (DA) reactions.3,4
In fact, a DA reaction is one of the most powerful cycloaddition
reactions in organic synthesis and particularly, in the construction
of 6-membered rings, combining dienes and dienophiles with
different substitution patterns.5,6 There are countless examples of
natural products and other complex structures synthesized through
this approach, with an outstanding degree of control and a high
level of predictability for this process.7 Inspired by the versatility of
an intermolecular DA reaction, intramolecular DA reactions has also
been employed in the total synthesis of several polycyclic natural
products, using one or multiple step strategies.8 Although some
chromone derivatives such as 2- or 3-styrylcromones have been
involved in DA reactions, either as dienes or dienophiles,9–12 to
the best of our knowledge, there are no reports involving
chromone derivatives in intramolecular DA reactions. Thus,
following our previous reports dealing with the reactivity of
(E)-2-(4-arylbut-1-en-3-yn-1-yl)chromones and (E,E)-2-(4-arylbuta-1,3-
dien-1-yl)chromones in DA reactions,13,14 herein we envisaged the
synthesis of novel propargyloxychromone derivatives to be used as
substrates in intramolecular DA reactions. This is the first report
involving chromone derivatives in intramolecular DA reactions
under microwave (MW) irradiation, allowing the synthesis of
chromeno[3,4-b]xanthones and 2-(benzo[c]chromenyl)chromones.
Moreover, the prepared compounds can present enhanced
biological properties since they combine the xanthone and
chromene nucleus, and the benzochromene and chromone
moieties in the same molecules (hybrid drug concept).15–18
Results and discussion
Synthesis of the starting chromones
The starting (E)-20-propargyloxy-2-styrylchromones 4a–d were
prepared in good yields (73–86%) through base-catalyzed aldol
condensation of the appropriate 2-methylchromone 2a–d with
ortho-propargyloxybenzaldehyde 3 [Scheme 1(ii)]. The required
benzaldehyde 3 was obtained by propargylation of the commercially
available salicylaldehyde 1 with propargyl bromide in the presence
of potassium carbonate in refluxing acetone [Scheme 1(i)].
The main features in the 1H NMR spectra of (E)-20-propargyloxy-
2-styrylchromones 4a–d are the presence of: (i) two doublets at d
6.81–6.91 and 7.81–7.94 ppm assigned to vinylic protons H-a and
H-b, respectively, in a trans configuration (3JHa–Hb 16.2 Hz); (ii) a
singlet at d 6.19–6.35 ppm assigned to proton H-3; and (iii) a
doublet and a triplet at d 4.83–4.85 and 2.58 ppm assigned to
protons H-100 and H-300, respectively (see Scheme 1 for numbering).
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The synthesis of (E,E)-2-[4-(2-propargyloxyphenyl)buta-1,3-
dien-1-yl]chromones was not straightforward. The initial strategy
involved the base-catalyzed aldol condensation of 2-methyl-
chromone 2a with the commercially available ortho-methoxy-
cinnamaldehyde 5, affording the methoxy substituted chromone
6a in good yield [Scheme 2(i)]. Then, the methyl group was
cleaved with boron tribromide and the propargylation was
accomplished with propargyl bromide in the presence of
potassium carbonate as a base, giving the desired O-propargyl-
2-butadienylchromone 7a with a good overall yield (85%)
[Scheme 2(ii) and (iii)]. This strategy was applied to the 2-methyl-
chromone derivative 2b, however, the demethylation step led
to the undesired cleavage of both methyl groups (20-OMe and
7-OMe). The analysis of the 1H NMR spectrum of the crude
product of the reaction with boron tribromide showed the
presence of two singlets corresponding to protons 20-OH and
7-OH, as well as another singlet corresponding to 7-OCH3. The
existence of a 7-OH group of the chromone moiety creates
another undesired propargylation site, avoiding the selective
propargylation of 20-OH. Therefore, it was necessary to employ
a different strategy for the synthesis of chromones 7b–d.
The new strategy relied on the preparation of a specific
cinnamaldehyde 10 with an appropriate ortho protecting group,
which could be selectively cleaved using less harsh conditions
(Scheme 3). Having this in mind, 2-iodophenol 8 was benzylated
with benzyl bromide (BnBr) in the presence of potassium
carbonate, affording the aryl iodide 9 in an almost quantitative
yield [Scheme 3(i)]. Then, the desired cinnamaldehyde 10 was
obtained through the palladium-catalyzed cross-coupling reaction
of aryl iodide 9 with acrolein diethyl acetal, following a previously
reported procedure19 [Scheme 3(ii)].
The base-catalyzed aldol condensation of 2-methylchromones
2b–d with cinnamaldehyde 10 afforded the desired chromones
6b–d in good yields [Scheme 4(i)]. The next step of this strategy
involved the selective cleavage of the benzyl group using a
mixture of AcOH/HCl (37%) (10% v/v), followed by propargylation
with propargyl bromide, which afforded the desired chromones
7b–d in overall good yields [Scheme 4(ii) and (iii)].
The main structural features found in the 1H NMR spectra of
chromones 7a–d are: (i) a doublet and a triplet at d 4.78–4.80
and 2.56–2.57 ppm assigned to protons H-100 and H-300, respec-
tively; (ii) a doublet at d 6.27–6.36 ppm assigned to proton H-a
in a trans configuration (3JHa–Hb = 15.2 Hz); and (iii) a doublet at
d 7.26–7.31 ppm assigned to proton H-d, in a trans configuration
as well (3JHa–Hb B 15.5–16.1 Hz) (see Scheme 4 for numbering).
Intramolecular Diels–Alder reactions
Once we achieved the synthesis of the propargyloxychromone
derivatives 4a–d and 7a–d, they were used as templates for
MW-assisted intramolecular DA reactions. The (E)-20-propargyloxy-
2-styrylchromone 4a was used as a model substrate to prepare
chromeno[3,4-b]xanthone derivatives. A careful optimization of the
reaction conditions under MW irradiation was performed. Several
attempts were carried out by varying the solvents, temperatures,
reaction times and Lewis acid activation (Table 1). Chromeno[3,4-
b]xanthone 12a was obtained in fair to good yields (38–60%)
using N-methyl-2-pyrrolidone (NMP) or 1,2,4-trichlorobenzene
(1,2,4-TCB) as solvents, at an increased temperature (Table 1,
entries 3–5). At a lower temperature and using DMF as the solvent
xanthone 12a was obtained in very low yield (Table 1, entries 3–5).
The formation of this compound could be explained on the basis
of a sequence of reactions involving firstly an intramolecular DA
reaction, followed by olefin migration and in situ oxidation to
afford chromeno[3,4-b]xanthone 12a (Scheme 5). To prove this
concept, derivative 11 was isolated in low yields (Table 1, entries
2–5, 7, 9 and 10) and its formation follows the same sequence of
reactions without the in situ oxidation step (Scheme 5). In order
to push the reaction towards the oxidized product, oxidizing
agents such as 1,4-benzoquinone, 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) and chloranil were added to the crude
reaction (Table 1, entries 6–8) and the best results were achieved
Scheme 1 Synthesis of (E)-20-propargyloxy-2-styrylchromones 4a–d.
Reagents and conditions: (i) K2CO3, acetone, reflux, 2 h; (ii) Na, EtOH,
r.t., 3–6 h.
Scheme 2 Synthesis of chromones 6a, 6aa and 7a. Reagents and
conditions: (i) Na, EtOH, r.t., 2–3 h; (ii) BBr3, CH2Cl2, r.t., 2 h; (iii) K2CO3,
propargyl bromide, acetone, reflux, 5 h.
Scheme 3 Synthesis of ortho-benzyloxycinnamaldehyde 10. Reagents
and conditions: (i) K2CO3, BnBr, acetone, reflux, 16 h; (ii) Acrolein diethyl
acetal, nBu4NOAc, K2CO3, Pd(OAc)2, DMF, 90 1C, 16 h.
Scheme 4 Synthesis of chromones 7b–d. Reagents and conditions:
(i) Na, EtOH, r.t., 4–6 h; (ii) AcOH/HCl (10% v/v), 100 1C, 16 h; (iii) K2CO3,
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in the presence of chloranil, being the chromeno[3,4-b]xanthone
12a obtained as the only product in a 75% yield (Table 1, entry 8).
The effect of the addition of a series of Lewis acids was
evaluated in solvent and solvent-free conditions, however, in all
cases, the chromeno[3,4-b]xanthone 12a was only obtained in
low yields (Table 1, entries 11–16). Attempts to perform the
reaction in solvent-free conditions were not advantageous
affording compound 12a in only 29–37% yield (Table 1, entries
17 and 18).
The best reaction conditions obtained for chromone derivative
4a were applied to derivatives 4b–d, affording the corresponding
chromeno[3,4-b]xanthones 12b–d in good yields (Scheme 6).
The chromeno[3,4-b]xanthones 12a–d were easily distinguished
from their chromone precursors 4a–d by the analysis of their
1H NMR spectra. The absence of the signals of the vinylic protons
H-a and H-b, as well as the signal of proton H-3, and the presence
of three singlets at d 8.04–8.12; 7.61–7.76 and 5.20–5.23 ppm
assigned to protons H-7, H-14 and H-6, respectively (see Scheme 6
for numbering), confirmed the structure of compounds 12a–d.
In the case of chromones 7a–d, the presence of two dienes
may lead to distinct intramolecular-DA products (reaction on
diene-3,2:a,b or diene-a,b:g,d – see Scheme 4 for numbering).
Previous work on MW-assisted DA reactions of similar butadienyl-
chromones with N-methylmaleimide as dienophile, showed that
the reaction is selective towards the most reactive diene-a,b:g,d in
the presence of scandium triflate as a Lewis acid.14 Therefore, the
intramolecular DA reaction of chromones 7a–d was carried out
using the optimized reaction conditions obtained for chromones
4a–d (Scheme 7). Interestingly, the (benzo[c]chromenyl)chromones
13a–d were obtained as the only product in good yields (78–85%)
(Scheme 7).
The main features observed in the 1H NMR spectra of
2-(benzo[c]chromenyl)chromones 13a–d are the presence of:
(i) a singlet at d 5.19–5.23 ppm assigned to protons H-100; (ii) a
doublet at d 7.78–7.84 ppm assigned to proton H-60; and (iii) a
double of doublets at d 7.86–7.94 ppm assigned to proton H-70.
Table 1 MW-assisted intramolecular DA reaction using (E)-20-propargyloxy-2-styrylchromone (4a)
Entry Solvent Lewis acidb T (1C) Time (min) 12a yielda (%) 11 yielda (%) 4a recovereda (%)
1 DMF — 165 40 4 — 93
2 DMF — 200 40 4 26 66
3 NMP — 200 40 38 20 33
4 1,2,4-TCB — 200 40 54 21 23
5 1,2,4-TCB — 200 60 60 10 20
6c 1,2,4-TCB — 200 60 10 — —
7d 1,2,4-TCB — 200 60 50 11 Traces
8e 1,2,4-TCB — 200 60 75 — Traces
9 1,2,4-TCB — 200 80 60 8 15
10 1,2,4-TCB — 220 60 50 8 14
11 1,2,4-TCB Sc(OTf)3 200 60 10 — —
12 1,2,4-TCB Sc(OTf)3 165 40 7 Traces 92
13 1,2,4-TCB SnCl2 200 60 8 Traces —
14 1,2,4-TCB AlCl3 200 60 10 Traces —
15 — Sc(OTf)3 165 40 3 — 91
16 — AuCl 200 40 6 — —
17 — — 200 40 29 — 51
18 — — 200 80 37 — 40
a Isolated yield. b 0.5 equiv. of Lewis acid. c Addition of 0.1 equiv. of DDQ to the crude mixture. Heating for 30 min at 100 1C under MW irradiation.
d Addition of 0.1 equiv. of 1,4-benzoquinone to the crude mixture. Heating for 30 min at 50 1C under MW irradiation. e Addition of 0.1 equiv. of
chloranil to the crude mixture. Heating for 30 min at 80 1C under MW irradiation. DMF = dimethylformamide; NMP = N-methyl-2-pyrrolidone;
1,2,4-TCB = 1,2,4-trichlorobenzene.
Scheme 5 Proposed mechanism for the formation of compounds 11 and
12a.
Scheme 6 MW-assisted synthesis of chromeno[3,4-b]xanthones 12a–d.
Reagents and conditions: (i) 1,2,4-TCB, MW, 200 1C, 60 min. Chloranil,
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Concerning the signal of proton H-90, it was observed as a
doublet at d 7.66–7.71 ppm for derivatives 13b–d, and as a
multiplet at d 7.69–7.75 ppm for derivative 13a (see Scheme 7 for
numbering). The absence of the signals corresponding to the
vinylic protons H-a, H-b, H-g and H-d, as well as the remaining
presence of the singlet assigned to proton H-3, clearly indicates
that the intramolecular DA reaction occurred in the diene-a,b:g,d,
followed by in situ dehydrogenation of the formed adduct.
So far, the reactivity of a terminal alkyne as the dienophile in
an intramolecular DA reaction was addressed in good overall
yields (75–85%). In addition, we decided to further evaluate the
same kind of reaction with a terminal alkene as dienophile.
Thus, the intramolecular DA reaction was also attempted in the
allyloxy-substituted chromone derivative 15.
Compound 15 was prepared as described for propargyloxy-
chromone 4a, using the commercially available 2-(allyloxy)-
benzaldehyde 14 [Scheme 8(i)]. Concerning the intramolecular
DA reaction on compound 15, two reaction attempts were
carried out. When the reaction was performed in DMF under
MW irradiation at 165 1C, compound 16 was obtained in 21%
yield, which results from the Claisen rearrangement of compound
15 [Scheme 8(ii)]. Increasing the reaction temperature to 200 1C
also under MW irradiation and using 1,2,4-TCB as a solvent,
complete degradation of the starting material was observed,
and several unidentified byproducts were obtained. This suggests
that the allyloxy substituent was not reactive as dienophile in
intramolecular DA reactions when compared to the propargyloxy
substituent.
The chromone derivative 17 was prepared through deprotection
of 6a, followed by allylation of the formed hydroxychromone
[Scheme 9(i)/(ii)]. Despite the unsuccessful intramolecular DA reac-
tion on compound 15, we also attempted it in compound 17 using
the same reaction conditions used for its analogue 7a [Scheme 9(iii)].
Unfortunately, the reaction afforded several unidentified byproducts
and no intramolecular DA product was observed.
Conclusions
In conclusion, we prepared in good yields a series of novel
(E)-20-[propargyloxy-2-styryl]chromones and (E,E)-2-[4-[2-(pro-
pargyloxyphenyl)buta-1,3-dien-1-yl]]chromones through base-
catalyzed aldol condensation of 2-methylchromones with the
appropriate salicylaldehyde and ortho-(methoxy/benzyloxy)-
cinnamaldehyde (in the latter case cleavage of the protecting
groups and propargylation steps were necessary), which were
further used as substrates in intramolecular DA reactions.
Chromeno[3,4-b]xanthones and 2-(benzo[c]chromenyl)chromones
were obtained via an MW-assisted intramolecular DA reaction,
followed by in situ dehydrogenation. 20-Allyloxy-2-stryrylchromone
and 20-allyloxy-2-(4-arylbuta-1,3-dien-1-yl)chromone derivatives
were also prepared and considered for intramolecular DA
reactions. However, in the first case, a Claisen rearrangement
product was obtained instead of the expected intramolecular
DA product; in the later case, the intramolecular DA reaction did




Melting points were measured with a Büchi B-540 apparatus.
NMR spectra were recorded with a Bruker Avance 300 (300.13 MHz
for 1H and 75.47 MHz for 13C) and 500 (500.13 MHz for 1H and
125.77 MHz for 13C) spectrometers. Chemical shifts (d) are reported
in ppm and coupling constants ( J) in Hz; the internal standard was
TMS. Unequivocal 13C assignments were made with the aid of 2D
gHSQC and gHMBC (delays for one-bond-long range JC/H couplings
were optimized for 145 and 7 Hz, respectively) experiments. Positive-
ion ESI mass spectra were acquired with a QTOF 2 instrument
[dilution of 1 mL] of the sample in chloroform solution (ca. 10–5 m)
in 200 mL of 0.1% trifluoroacetic acid/methanol solution. Nitrogen
was used as the nebuliser gas and argon as the collision gas. The
needle voltage was set at 3000 V, with the ion source at 80 1C and the
desolvation temperature at 150 1C. The cone voltage was 35 V. Other
low- and high-resolution mass spectra (EI, 70 eV) were measured
with VG Autospec Q and M spectrometers. Preparative thin-layer
chromatography was performed with Merck silica gel (60 DGF254).
All chemicals and solvents used were obtained from commercial
sources and used as received or dried using standard procedures.
Scheme 7 MW-assisted synthesis of 2-(benzo[c]chromenyl)chromones
13a–d. Reagents and conditions: (i) 1,2,4-TCB, MW, 200 1C, 60 min and
then chloranil, MW, 80 1C, 30 min.
Scheme 8 Synthesis and Claisen rearrangement of chromone 15. Reagents
and conditions: (i) Na, EtOH, r.t., 2 h; (ii) DMF, MW, 165 1C, 40 min.
Scheme 9 Synthesis of chromone derivative 17. Reagents and conditions:
(i) BBr3, CH2Cl2, r.t., 2 h; (ii) K2CO3, allyl bromide, acetone, reflux, 4 h;
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MW-assisted reactions were carried out in a CEM Discover SP
apparatus.
Synthetic procedures
General procedure for the synthesis of 2-methyl-4H-chromen-4-
ones 2a–d. The 2-methylchromones 2a–d were synthesized
according to procedures previously described in the literature
and showed identical spectroscopic and analytical data.20
General procedure for the synthesis of 2-(prop-2-yn-1-yloxy)-
benzaldehyde 3. K2CO3 (6.84 g, 49.5 mmol) and propargyl
bromide (3.22 mL, 36.3 mmol) were added to a solution of
salicylaldehyde (4.0 g, 33 mmol) in acetone (100 mL). The
resulting mixture was refluxed for 2 h. After that period, the
reaction mixture was poured into ice (100 g) and water (100 mL)
and the pH adjusted to 4 with dilute HCl (10%). The precipitate
was recovered via filtration and washed with water (50 mL).
White solid; yield 5.0 g (95%); m.p. 68–70 1C (Lit. 69–70 1C).21
1H NMR (300 MHz, CDCl3): d 2.58 (t, 1H, H-30, J 2.4 Hz), 4.84 (d,
2H, H-10, J 2.4 Hz), 7.07–7.14 (m, 2H, H-3, H-5), 7,58 (ddd, 1H,
H-4, J 8.3; 7.3; 1.8 Hz), 7.87 (dd, 1H, H-6, J 7.7; 1.8 Hz), 10.49 (s,
1H, CHO) ppm.
General procedure for the synthesis of (E)-2-[2-(prop-2-yn-1-
yloxy)styryl]chromones 4a–d. To a mixture of sodium (110 mg,
5 mmol) in ethanol (5 mL) was added the appropriate 2-methyl-
chromone 2a–d (1.25 mmol) and the O-propargylbenzaldehyde
3 (250 mg, 1.56 mmol). The resulting mixture was stirred at
room temperature for 3–6 h. After that period, the mixture was
poured into ice (20 g) and water (30 mL) and the pH was
adjusted to 4 with dilute HCl (10%). The precipitate was
removed via filtration, taken in CH2Cl2 and purified using
silica gel column chromatography using CH2Cl2 as the eluent.
(E)-2-[2-(Prop-2-yn-1-yloxy)styryl]chromone (4a). Light green
solid; yield 325 mg (86%); m.p. 137–138 1C. 1H NMR (500 MHz,
CDCl3): d 2.58 (t, 1H, H-300, J 2.4 Hz), 4.85 (d, 2H, H-100, J 2.4 Hz),
6.35 (s, 1H, H-3), 6.91 (d, 1H, H-a, J 16.2 Hz), 7.07 (ddd, 1H, H-50
J 7.6; 7.4; 1.0 Hz), 7.09 (dd, 1H, H-30, J 8.6; 1.0 Hz), 7.37 (ddd, 1H,
H-40, J 8.6; 7.4; 1.7 Hz), 7.40 (ddd, 1H, H-6, J 8.0; 7.1; 1.1 Hz), 7.57
(dd, 1H, H-8, J 8.5; 1.1 Hz), 7.62 (dd, 1H, H-60, J 7.6; 1.7 Hz), 7.69
(ddd, 1H, H-7, J 8.5; 7.1; 1.7 Hz), 7.94 (d, 1H, H-b, J 16.2 Hz), 8.20
(dd, 1H, H-5, J 8.0; 1.7 Hz) ppm. 13C NMR (125 MHz, CDCl3): d 56.3
(C-100), 76.1 (C-300), 78.2 (C-200), 110.5 (C-3), 112.8 (C-30), 118.0 (C-8),
121.2 (C-a), 121.9 (C-50), 124.2 (C-4a), 124.7 (C-10), 124.9 (C-6), 125.7
(C-5), 128.3 (C-60), 130.9 (C-40), 132.0 (C-b), 133.7 (C-7), 155.9 (C-20),
156.1 (C-8a), 162.3 (C-2), 178.6 (C-4) ppm. HRMS (ESI+): m/z
[M + H]+ calcd for C20H15O3: 303.1021; found 303.1011.
(E)-7-Methoxy-2-[2-(prop-2-yn-1-yloxy)styryl]chromone (4b). Light
yellow solid; yield 303 mg (73%); m.p. 151–153 1C. 1H NMR
(500 MHz, CDCl3): d 2.58 (t, 1H, H-300, J 2.4 Hz), 3.95 (s, 3H,
7-OCH3), 4.85 (d, 2H, H-100, J 2.4 Hz), 6.28 (s, 1H, H-3), 6.88 (d, 1H,
H-a, J 16.2 Hz), 6.95-6.98 (m, 2H, H-6, H-8), 7.05-7.10 (m, 2H,
H-30, H-50), 7.37 (ddd, 1H, H-40, J 8.3; 7.3; 1.7 Hz), 7.61 (dd, 1H,
H-60, J 7.7; 1.7 Hz), 7.89 (d, 1H, H-b, J 16.2 Hz), 8.10 (d, 1H, H-5,
J 9.2 Hz) ppm. 13C NMR (75 MHz, CDCl3): d 55.9 (C-100), 56.3
(7-OCH3), 76.1 (C-300), 78.2 (C-200), 100.4 (C-8), 110.5 (C-3),
112.8 (C-30), 114.1 (C-6), 118.1 (C-4a), 121.3 (C-a), 121.9 (C-50),
124.8 (C-10), 127.0 (C-5), 128.2 (C-60), 130.7 (C-40), 131.4 (C-b),
155.8 (C-20), 157.8 (C-8a), 161.9 (C-2), 164.1 (C-7), 178.0 (C-4) ppm.
HRMS (ESI+): m/z [M + H]+ calcd for C21H17O4: 333.1121; found
333.1123.
(E)-5-Methoxy-2-[2-(prop-2-yn-1-yloxy)styryl]chromone (4c). Light
yellow solid; yield 311 mg (75%); m.p. 180–182 1C. 1H NMR
(500 MHz, CDCl3): d 2.58 (t, 1H, H-300, J 2.3 Hz), 3.99 (s, 3H,
5-OCH3), 4.83 (d, 2H, H-100, J 2.3 Hz), 6.26 (s, 1H, H-3), 6.80 (d, 1H,
H-6, J 8.3 Hz), 6.83 (d, 1H, H-a, J 16.2 Hz), 7.06 (dt, 1H, H-50, J 7.5;
0.9 Hz), 7.07 (dd, 1H, H-30, J 8.5; 0.9 Hz), 7.13 (dd, 1H, H-8, J 8.3;
0.9 Hz), 7.36 (ddd, 1H, H-40, J 8.5; 7.5; 0.9 Hz), 7.56 (t, 1H, H-7,
J 8.3 Hz), 7.59 (dd, 1H, H-60, J 7.5; 1.7 Hz), 7.85 (d, 1H, H-b,
J 16.2 Hz) ppm. 13C NMR (75 MHz, CDCl3): d 56.3 (C-100), 56.5
(5-OCH3), 76.1 (C-300), 78.2 (C-200), 106.2 (C-6), 110.2 (C-8), 112.1 (C-3),
112.8 (C-30), 114.8 (C-4a), 120.9 (C-a), 121.8 (C-50), 124.8 (C-10), 128.2
(C-60), 130.6 (C-40), 131.4 (C-b), 133.6 (C-7), 155.8 (C-20), 158.1
(C-8a), 159.7 (C-5), 160.1 (C-2), 178.5 (C-4) ppm. HRMS (ESI+): m/z
[M + H]+ calcd for C21H17O4: 333.1121; found 333.1129.
(E)-5,7-Dimethoxy-2-[2-(prop-2-yn-1-yloxy)styryl]chromone (4d).
White solid; yield 331 mg (73%); m.p. 190–193 1C. 1H NMR
(500 MHz, CDCl3): d 2.58 (t, 1H, H-300, J 2.4 Hz), 3.93 (s, 3H,
7-OCH3), 3.95 (s, 3H, 5-OCH3), 4.84 (d, 2H, H-100, J 2.4 Hz), 6.19
(s, 1H, H-3), 6.36 (d, 1H, H-6, J 2.3 Hz), 6.58 (d, 1H, H-8,
J 2.3 Hz), 6.81 (d, 1H, H-a, J 16.2 Hz), 7.04–7.07 (m, 1H, H-50),
7.08 (dd, 1H, H-30, J 8.4; 1.0 Hz), 7.35 (ddd, 1H, H-40, J 8.4; 7.3;
1.7 Hz), 7.59 (dd, 1H, H-60, J 7.7; 1.7 Hz), 7.81 (d, 1H, H-b,
J 16.2 Hz) ppm. 13C NMR (75 MHz, CDCl3): d 55.8 (7-OCH3), 56.2
(C-100), 56.4 (5-OCH3), 76.1 (C-300), 78.2 (C-200), 92.9 (C-8), 96.0
(C-6), 109.8 (C-4a), 112.1 (C-3), 112.8 (C-30), 121.0 (C-50), 121.9
(C-a), 124.9 (C-10), 128.2 (C-60), 130.5 (C-40), 130.8 (C-b), 155.8
(C-20), 159.6 and 159.7 (C-2 and C-8a), 160.9 (C-5), 164.0 (C-7),
177.8 (C-4) ppm. HRMS (ESI+): m/z [M + H]+ calcd for C22H19O5:
363.1227; found 363.1229.
Synthesis of (E,E)-2-[4-(2-methoxyphenyl)buta-1,3-dien-1-yl]-
chromone (6a) and (E,E)-7-methoxy-2-[4-(2-methoxyphenyl)buta-
1,3-dien-1-yl]chromone (6aa). To a mixture of sodium (110 mg,
5 mmol) in ethanol (5 mL) was added the appropriate 2-methyl-
chromone 2a and 2b (1.15 mmol) and the ortho-methoxy-
cinnamaldehyde 5 (253 mg, 1.56 mmol). The resulting mixture
was stirred at room temperature for 2–3 h. After that period, the
mixture was poured into ice (20 g) and water (30 mL) and the pH
was adjusted to 4 with dilute HCl (10%). The precipitate was
removed via filtration, taken in CH2Cl2 and purified using silica
gel column chromatography using CH2Cl2 as the eluent.
(E,E)-2-[4-(2-Methoxyphenyl)buta-1,3-dien-1-yl]chromone (6a).
Yellow solid; yield 285 mg (75%); m.p. 103–105 1C. 1H NMR
(300 MHz, CDCl3): d 3.91 (s, 3H, 20-OCH3), 6.25 (s, 1H, H-3), 6.35
(d, 1H, H-a, J 15.3 Hz), 6.92 (dd, 1H, H-30, J 8.3; 1.0 Hz), 6.98 (dt,
1H, H-50, J 7.6; 1.0 Hz), 6.98–7.07 (m, 1H, H-g), 7.27–7.32 (m,
2H, H-40, H-d), 7.38 (ddd, 1H, H-6, J 8.0; 7.1; 1.1 Hz), 7.42–7.51
(m, 1H, H-b), 7.49 (dd, 1H, H-8, J 8.7; 1.1 Hz), 7.54 (dd, 1H,
H-60, J 7.6; 1.7 Hz), 7.67 (ddd, 1H, H-7, J 8.7; 7.1; 1.7 Hz), 8.19
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d 55.5 (20-OCH3), 110.1 (C-3), 111.1 (C-30), 117.8 (C-8), 120.8
(C-50), 122.9 (C-a), 124.2 (C-4a), 124.9 (C-6), 125.2 (C-10), 125.7
(C-5), 127.3 (C-60), 127.7 (C-g), 130.1 (C-40), 133.6 (C-7), 134.4
(C-d), 138.5 (C-b), 156.0 (C-8a), 157.4 (C-20), 162.1 (C-2), 178.4
(C-4) ppm. HRMS (ESI+): m/z [M + H]+ calcd for C20H17O3:
305.1178; found 305.1170.
(E,E)-7-Methoxy-2-[4-(2-methoxyphenyl)buta-1,3-dien-1-yl]chromone
(6aa). Yellow solid; yield 308 mg (80%); m.p. 129–131 1C.1H NMR
(500 MHz, CDCl3): d 3.90 (s, 3H, 20-OCH3), 3.93 (s, 3H, 7-OCH3), 6.19
(s, 1H, H-3), 6.33 (d, 1H, H-a, J 15.2 Hz), 6.90 (d, 1H, H-8, J 2.4 Hz),
6.90–6.92 (m, 1H, H-30), 6.95 (dd, 1H, H-6, J 8.8; 2.4 Hz), 6.96–6.99
(m, 1H, H-50), 7.02 (ddd, 1H, H-g, J 15.7; 11.0; 0.8 Hz), 7.26–7.29 (m,
1H, H-d), 7.29 (ddd, 1H, H-40, J 8.2; 7.4; 1.7 Hz), 7.43 (ddd, 1H, H-b,
J 15.2; 11.0; 0.8 Hz), 7.53 (dd, 1H, H-60, J 7.7; 1.7 Hz), 8.09 (d, 1H,
H-5, J 8.8 Hz) ppm. 13C NMR (75 MHz, CDCl3): d 55.5 (20-OCH3),
55.8 (7-OCH3), 100.2 (C-8), 110.0 (C-3), 111.1 (C-30), 113.9 (C-6),
118.0 (C-4a), 120.8 (C-50), 122.9 (C-a), 125.3 (C-10), 127.0 (C-5), 127.2
(C-60), 127.7 (C-g), 130.0 (C-40), 134.0 (C-d), 137.9 (C-b), 157.3 (C-20),
157.7 (C-8a), 161.7 (C-2), 164.1 (C-7), 177.9 (C-4) ppm.
Synthesis of (E,E)-2-{4-[2-(prop-2-yn-1-yloxy)phenyl]buta-1,3-
dien-1-yl}chromone (7a). A solution of BBr3 in CH2Cl2 1M
(1.64 mL) was added to a solution of chromone derivative 6a
(200 mg, 0.657 mmol) in CH2Cl2 (5 mL) under a nitrogen atmo-
sphere. The resulting mixture was stirred at room temperature for
2 h. After that period, the mixture was poured into ice (5 g) and
water (15 mL) and the slurry was stirred until the formation of a
precipitate was achieved. The precipitate was removed via filtration
and washed with water (100 mL) and ethyl ether (50 mL). To a
stirring mixture of the precipitate in acetone (30 mL) was added
K2CO3 (136 mg, 1.5 equiv.) and propargyl bromide 80% m/m in
xylene (0.2 mL; 3 equiv.). The resulting mixture was stirred at reflux
for 5 h. After that period, the mixture was poured into ice (5 g) and
water (15 mL) and the pH was adjusted to 4 with dilute HCl (10%).
The aqueous layer was extracted with CH2Cl2 (3  50 mL), dried
over anhydrous Na2SO4 and the solvent evaporated to dryness. The
residue was purified using preparative TLC using CH2Cl2/EtOAc
(5 : 1) as the eluent.
Orange solid; yield 183 mg (85%); m.p. 160–162 1C. 1H NMR
(500 MHz, CDCl3): d 2.57 (t, 1H, H-300, J 2.4 Hz), 4.80 (d, 2H,
H-100, J 2.4 Hz), 6.26 (s, 1H, H-3), 6.36 (d, 1H, H-a, J 15.2 Hz),
6.97-7.06 (m, 3H, H-30, H-50, H-g), 7.28–7.34 (m, 1H, H-40), 7.31
(d, 1H, H-d, J 15.7 Hz), 7.39 (ddd, 1H, H-6, J 7.9; 7.1; 0.8 Hz),
7.43-7.52 (m, 1H, H-b), 7.51 (dd, 1H, H-8, J 8.5; 0.8 Hz), 7.57 (dd,
1H, H-60, J 7.9; 1.6 Hz), 7.68 (ddd, 1H, H-7, J 8.5; 7.1; 1.7 Hz),
8.19 (dd, 1H, H-5, J 7.9; 1.7 Hz) ppm. 13C NMR (125 MHz,
CDCl3): d 56.3 (C-100), 75.9 (C-300), 78.3 (C-200), 110.2 (C-3), 112.7
(C-30), 117.8 (C-8), 121.8 (C-50), 123.2 (C-a), 124.2 (C-4a), 124.9
(C-6), 125.7 (C-5), 125.9 (C-10), 127.2 (C-60), 127.9 (C-g), 129.9
(C-40), 133.7 (C-7), 133.9 (C-d), 138.3 (C-b), 155.3 (C-20), 156.0
(C-8a), 162.0 (C-2), 178.5 (C-4) ppm. HRMS (ESI+): m/z [M + H]+
calcd for C22H17O3: 329.1172; found 329.1175.
General procedure for the synthesis of (E,E)-2-{4-[2-(benzyl-
oxy)phenyl]buta-1,3-dien-1-yl}chromones 6b–d. To a mixture of
sodium (110 mg, 5 mmol) in ethanol (5 mL) was added the
appropriate 2-methylchromone 2b–d (1.25 mmol) and the
ortho-benzyloxycinnamaldehyde 10 (372 mg, 1.56 mmol). The
resulting mixture was stirred at room temperature for 4–6 h.
After that period, the mixture was poured into ice (20 g) and
water (30 mL) and the pH was adjusted to 4 with dilute HCl (10%).
The precipitate was removed via filtration, taken in CH2Cl2 and
purified using silica gel column chromatography using CH2Cl2 as
the eluent.
(E,E)-2-{4-[2-(Benzyloxy)phenyl]buta-1,3-dien-1-yl}-7-methoxy-
chromone (6b). Yellow solid; yield 436 mg (85%); m.p. 139–142 1C.
1H NMR (500 MHz, CDCl3): d 3.91 (s, 3H, 7-OCH3), 5.14 (s, 2H,
20-OCH2C6H5), 6.16 (s, 1H, H-3), 6.27 (d, 1H, H-a, J 15.2 Hz), 6.90
(d, 1H, H-8, J 2.3 Hz), 6.93 (dd, 1H, H-6, J 8.8; 2.3 Hz), 6.96–7.04 (m,
3H, H-g, H-30, H-50), 7.27 (ddd, 1H, H-40, J 8.2; 7.4; 1.6 Hz), 7.32 (d,
1H, H-d, J 15.7 Hz), 7.37–7.49 (m, 6H, H-b, 20-OCH2C6H5), 7.57 (dd,
1H, H-60, J 7.7; 1.6 Hz), 8.08 (d, 1H, H-5, J 8.8 Hz) ppm. 13C NMR
(125 MHz, CDCl3): d 55.9 (7-OCH3), 70.4 (20-OCH2C6H5), 100.2
(C-8), 110.1 (C-3), 112.5 (C-30), 114.1 (C-6), 118.0 (C-4a), 121.2 (C-50),
123.1 (C-a), 125.6 (C-10), 127.0 (C-5), 127.1 (C-60), 127.6 (C-2,6 of
20-OCH2C6H5), 127.8 (C-g), 128.2 (C-4 of 20-OCH2C6H5), 128.7
(C-3,5 of 20-OCH2C6H5), 130.0 (C-40), 133.7 (C-d), 136.8 (C-1 of
20-OCH2C6H5), 137.8 (C-b), 156.5 (C-20), 157.8 (C-8a), 161.6 (C-2),
164.1 (C-7), 177.9 (C-4) ppm. HRMS (ESI+): m/z [M + H]+ calcd for
C27H23O4: 411.1591; found 411.1601.
(E,E)-2-{4-[2-(Benzyloxy)phenyl]buta-1,3-dien-1-yl}-5-methoxy-
chromone (6c). Yellow solid; yield 410 mg (80%); m.p. 125–
127 1C. 1H NMR (500 MHz, CDCl3): d 3.98 (s, 3H, 5-OCH3), 5.15
(s, 2H, 20-OCH2C6H5), 6.15 (s, 1H, H-3), 6.23 (d, 1H, H-a,
J 15.3 Hz), 6.79 (dd, 1H, H-6, J 8.4; 0.9 Hz), 6.97 (dd, 1H, H-30,
J 8.4; 1.0 Hz), 6.97–7.05 (m, 2H, H-g, H-50), 7.07 (dd, 1H, H-8,
J 8.4; 0.9 Hz), 7.25–7.28 (m, 1H, H-40), 7.30 (d, 1H, H-d,
J 15.7 Hz), 7.34–7.49 (m, 6H, H-b, 20-OCH2C6H5), 7.53 (t, 1H,
H-7, J 8.4 Hz), 7.56 (dd, 1H, H-60, J 7.6; 1.5 Hz) ppm. 13C NMR
(125 MHz, CDCl3): d 56.5 (5-OCH3), 70.4 (20-OCH2C6H5), 106.2
(C-6), 110.0 (C-8), 111.7 (C-3), 112.5 (C-30), 114.7 (C-4a), 121.1
(C-50), 122.6 (C-a), 125.7 (C-10), 127.2 (C-60), 127.6 (C-2,6 of
20-OCH2C6H5), 127.9 (C-g), 128.1 (C-4 of 20-OCH2C6H5), 128.7
(C-3,5 of 20-OCH2C6H5), 129.9 (C-40), 133.6 and 133.7 (C-d and
C-7), 136.8 (C-1 of 20-OCH2C6H5), 137.8 (C-b), 156.5 (C-20), 158.1
(C-8a), 159.7 and 159.9 (C-2 and C-5), 178.4 (C-4) ppm. HRMS (ESI+):
m/z [M + H]+ calcd for C27H23O4: 411.1591; found 411.1596.
(E,E)-2-{4-[2-(Benzyloxy)phenyl]buta-1,3-dien-1-yl}-5,7-dimethoxy-
chromone (6d). Yellow solid; yield 385 mg (70%); m.p. 180–183 1C.
1H NMR (500 MHz, CDCl3): d 3.90 (s, 3H, 7-OCH3), 3.93 (s, 3H,
5-OCH3), 5.14 (s, 2H, 20-OCH2C6H5), 6.09 (s, 1H, H-3), 6.21 (d, 1H,
H-a, J 15.3 Hz), 6.34 (d, 1H, H-6, J 2.3 Hz), 6.52 (d, 1H, H-8,
J 2.3 Hz), 6.96-7.03 (m, 3H, H-30, H-50, H-g), 7.25–7.28 (m, 1H, H-40),
7.29 (d, 1H, H-d, J 15.8 Hz), 7.33–7.49 (m, 6H, H-b, 20-OCH2C6H5),
7.56 (dd, 1H, H-60, J 7.7; 1.7 Hz) ppm. 13C NMR (125 MHz, CDCl3):
d 55.8 (7-OCH3), 56.4 (5-OCH3), 70.4 (20-OCH2C6H5), 92.7 (C-8),
96.0 (C-6), 109.4 (C-4a), 111.8 (C-3), 112.5 (C-30), 121.1 (C-50), 122.7
(C-a), 125.7 (C-10), 127.1 (C-60), 127.6 (C-2,6 of 20-OCH2C6H5), 127.9
(C-g), 128.2 (C-4 of 20-OCH2C6H5), 128.7 (C-3,5 of 20-OCH2C6H5),
129.9 (C-40), 133.2 (C-d), 136.8 (C-1 of 20-OCH2C6H5), 137.2 (C-b),
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177.7 (C-4) ppm. HRMS (ESI+): m/z [M + H]+ calcd for C28H25O5:
441.1697; found 441.1714.
General procedure for the synthesis of (E,E)-2-{4-[2-(prop-2-
yn-1-yloxy)phenyl]buta-1,3-dien-1-yl}chromones 7b–d. To a stirring
mixture of AcOH/HCl 37% (10% v/v) (10 mL) was added the
appropriate chromone derivative 6b–d (0.487 mmol). The resulting
mixture was stirred at 100 1C for 16 h. After that period, the
mixture was poured into ice (5 g) and water (15 mL), the aqueous
layer was extracted with EtOAc (3  50 mL), dried over anhydrous
Na2SO4 and the solvent evaporated to dryness. To a stirring
mixture of the residue in acetone (30 mL) was added K2CO3
(101 mg, 1.5 equiv.) and propargyl bromide 80% m/m in xylene
(0.13 mL, 3 equiv.). The mixture was refluxed for 5 h. After that
period, the mixture was poured into ice (5 g) and water (15 mL)
and the pH was adjusted to 4 with dilute HCl (10%). The aqueous
layer was extracted with CH2Cl2 (3 50 mL), dried over anhydrous
Na2SO4 and the solvent evaporated to dryness. The residue was
purified via preparative TLC using CH2Cl2/EtOAc (5 : 1) as the
eluent.
(E,E)-7-Methoxy-2-{4-[2-(prop-2-yn-1-yloxy)phenyl]buta-1,3-dien-
1-yl}chromone (7b). Yellow solid; yield 145 mg (83%); m.p. 137–
139 1C. 1H NMR (300 MHz, CDCl3): d 2.57 (t, 1H, H-300, J 2.4 Hz),
3.93 (s, 3H, 7-OCH3), 4.79 (d, 2H, H-100, J 2.4 Hz), 6.19 (s, 1H,
H-3), 6.33 (d, 1H, H-a, J 15.2 Hz), 6.91-7.05 (m, 5H, H-6, H-8,
H-30, H-50, H-g), 7.29 (d, 1H, H-d, J 16.1 Hz), 7.26–7.33 (m, 1H,
H-40), 7.43 (dd, 1H, H-b, J 15.2; 10.9 Hz), 7.56 (dd, 1H, H-60,
J 7.9; 1.7 Hz), 8.09 (d, 1H, H-5, J 8.8 Hz) ppm. 13C NMR (75 MHz,
CDCl3): d 55.8 (7-OCH3), 56.3 (C-100), 75.8 (C-300), 78.4 (C-200),
100.2 (C-8), 110.2 (C-3), 112.7 (C-30), 114.0 (C-6), 118.0 (C-4a),
121.8 (C-50), 123.2 (C-a), 125.9 (C-10), 127.0 (C-5), 127.2 (C-60), 127.9
(C-g), 129.8 (C-40), 133.5 (C-d), 137.7 (C-b), 155.3 (C-20), 157.7 (C-8a),
161.6 (C-2), 164.1 (C-7), 177.9 (C-4) ppm. HRMS (ESI+): m/z [M + H]+
calcd for C23H19O4: 359.1278; found 359.1285.
(E,E)-5-Methoxy-2-{4-[2-(prop-2-yn-1-yloxy)phenyl]buta-1,3-dien-
1-yl}chromone (7c). Yellow solid; yield 140 mg (80%); m.p.
103–105 1C. 1H NMR (500 MHz, CDCl3): d 2.56 (t, 1H, H-300,
J 2.4 Hz), 3.98 (s, 3H, 5-OCH3), 4.79 (d, 2H, H-100, J 2.4 Hz), 6.17
(s, 1H, H-3), 6.29 (d, 1H, H-a, J 15.2 Hz), 6.80 (dd, 1H, H-6, J 8.4;
1.0 Hz), 6.97–7.04 (m, 3H, H-30, H-50, H-g), 7.07 (dd, 1H, H-8,
J 8.4; 1.0 Hz), 7.27 (d, 1H, H-d, J 15.5 Hz), 7.28–7.31 (m, 1H, H-40),
7.39 (ddd, 1H, H-b, J 15.2; 11.0; 0.9 Hz), 7.55 (t, 1H, H-7,
J 8.4 Hz), 7.56 (dd, 1H, H-60, J 7.9; 1.7 Hz) ppm. 13C NMR
(75 MHz, CDCl3): d 56.3 (C-100), 56.5 (5-OCH3), 75.8 (C-300), 78.4
(C-200), 106.2 (C-6), 110.0 (C-8), 111.8 (C-3), 112.7 (C-30), 114.7
(C-4a), 121.8 (C-50), 122.8 (C-a), 126.0 (C-10), 127.2 (C-60), 128.0
(C-g), 129.8 (C-40), 133.3 (C-d), 133.6 (C-7), 137.6 (C-b), 155.2
(C-20), 158.1 (C-8a), 159.8 (C-2 and C-5), 178.4 (C-4) ppm. HRMS
(ESI+): m/z [M + H]+ calcd for C23H19O4: 359.1278; found 359.1285.
(E,E)-5,7-Dimethoxy-2-{4-[2-(prop-2-yn-1-yloxy)phenyl]buta-1,3-
dien-1-yl}chromone (7d). Yellow solid; yield 142 mg (75%); m.p.
95–98 1C. 1H NMR (500 MHz, CDCl3): d 2.56 (t, 1H, H-300,
J 2.4 Hz), 3.92 (s, 3H, 7-OCH3), 3.94 (s, 3H, 5-OCH3), 4.78 (d,
2H, H-100, J 2.4 Hz), 6.11 (s, 1H, H-3), 6.27 (d, 1H, H-a, J 15.2 Hz),
6.35 (d, 1H, H-6, J 2.3 Hz), 6.52 (d, 1H, H-8, J 2.3 Hz), 6.96–7.02
(m, 3H, H-30, H-50, H-g), 7.26 (d, 1H, H-d, J 15.7 Hz), 7.27–7.31
(m, 1H, H-40), 7.36 (ddd, 1H, H-b, J 15.2; 11.0; 0.9 Hz), 7.56 (dd,
1H, H-60, J 8.0; 1.6 Hz) ppm. 13C NMR (125 MHz, CDCl3): d 55.8
(7-OCH3), 56.3 (C-100), 56.4 (5-OCH3), 75.8 (C-300), 78.4 (C-200),
92.7 (C-8), 96.0 (C-6), 109.4 (C-4a), 111.8 (C-3), 112.7 (C-30),
121.8 (C-50), 122.9 (C-a), 126.0 (C-10), 127.1 (C-60), 128.0 (C-g),
129.7 (C-40), 133.0 (C-d), 137.1 (C-b), 155.2 (C-20), 159.3 (C-2),
159.7 (C-8a), 160.9 (C-5), 164.0 (C-7), 177.7 (C-4) ppm. HRMS (ESI+):
m/z [M + H]+ calcd for C24H21O5: 389.1384; found 389.1399.
Synthesis of 1-benzyloxy-2-iodobenzene (9). K2CO3 (1.89 g,
13.6 mmol) and benzyl bromide (1.19 mL, 10.0 mmol) were
added to a solution of 2-iodophenol 8 (2 g, 9.1 mmol) in acetone
(100 mL). The resulting mixture was stirred at reflux for 16 h.
After that period, the mixture was poured into ice (100 g) and
water (100 mL) and the pH was adjusted to 4 with dilute
HCl (10%). The aqueous layer was extracted with CH2Cl2 (3 
100 mL), dried over anhydrous Na2SO4 and the solvent evaporated
to dryness. Colorless oil; yield 2.80 g (99%). 1H NMR (300 MHz,
CDCl3): d 5.15 (s, 2H, 1-OCH2C6H5), 6.72 (dt, 1H, H-4, J 7.6; 1.4 Hz),
6.86 (dd, 1H, H-6, J 8.2; 1.4 Hz), 7.27 (ddd, 1H, H-5, J 8.2; 7.6;
1.6 Hz), 7.32-7.51 (m, 5H, 1-OCH2C6H5), 7.80 (dd, 1H, H-3, J 7.6;
1.6 Hz) ppm. 13C NMR (75 MHz, CDCl3): d 70.8 (1-OCH2C6H5),
86.8 (C-2), 112.7 (C-6), 122.8 (C-4), 127.0 (C-2,6 of 1-OCH2C6H5),
127.9 (C-4 of 1-OCH2C6H5), 128.6 (C-3,5 of 1-OCH2C6H5), 129.4
(C-5), 136.5 (C-1 of 1-OCH2C6H5), 139.6 (C-3), 157.2 (C-1) ppm.
HRMS (ESI+): m/z [M + H]+ calcd for C13H12IO: 310.9933; found
310.9938.
Synthesis of (E)-3-[2-(benzyloxy)phenyl]acrylaldehyde (10).
Acrolein diethyl acetal (4.1 mL, 27 mmol), nBu4NOAc (5.4 g,
18 mmol), K2CO3 (1.86 g, 13.5 mmol) and Pd(OAc)2 (61 mg,
0.27 mmol) were added to a solution of 1-benzyloxy-2-iodobenzene
9 (2.80 g, 9 mmol) in DMF (10 mL). The mixture was stirred at 90 1C
for 16 h. After that period, the mixture was poured into ice (50 g) and
water (50 mL), the pH was adjusted to 1 with dilute HCl (10%), and
the aqueous mixture was stirred at room temperature for 15 min.
Then, it was extracted with Et2O (3 100 mL), dried over anhydrous
Na2SO4 and the solvent evaporated to dryness. The crude residue
was purified using silica gel column chromatography using CH2Cl2
as the eluent. White solid; yield 1.50 g (70%); m.p. 56–58 1C. 1H NMR
(300 MHz, CDCl3): d 5.16 (s, 2H, 2-OCH2C6H5), 6.77 (dd, 1H,
H-a, J 16.1; 7.9 Hz), 6.98–7.01 (m, 1H, H-5), 6.99 (d, 1H, H-3,
J 7.9 Hz), 7.33–7.44 (m, 6H, 2-OCH2C6H5, H-4), 7.58 (dd, 1H, H-6,
J 8.1; 1.7 Hz), 7.90 (d, 1H, H-b, J 16.1 Hz), 9.66 (d, 1H, CHO,
J 7.9 Hz) ppm. 13C NMR (75 MHz, CDCl3): d 70.6 (2-OCH2C6H5),
112.8 (C-3), 121.2 (C-5), 123.3 (C-1), 127.4 (C-2,6 of 2-OCH2C6H5),
128.3 (C-4 of 2-OCH2C6H5), 128.7 (C-6), 128.8 (C-3,5 of 2-OCH2C6H5),
129.0 (C-a), 132.7 (C-4), 136.3 (C-1 of 2-OCH2C6H5), 148.0 (C-b),
157.4 (C-2), 194.6 (CHO) ppm. HRMS (ESI+): m/z [M + Na]+ calcd for
C16H14O2Na: 261.0886; found 261.0890.
Synthesis of 14,14a-dihydro-6H,8H-chromeno[3,4-b]xanthen-
8-one (11). This compound was isolated from the MW-assisted
intramolecular DA reaction of chromone derivative 4a (0.1 mmol,
30 mg) in DMF, NMP or 1,2,4-TCB as solvents (see Table 1). White
solid; m.p. 215–217 1C. 1H NMR (500 MHz, CDCl3): d 2.89 (t, 1H,
H-14, J 17.1 Hz), 3.27 (dd, 1H, H-14, J 17.1; 8.1 Hz), 4.09 (ddd,
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4.78 (d, 1H, H-6, J 12.5 Hz), 6.85 (dd, 1H, H-7, J 3.2; 1.8 Hz), 6.97
(dd, 1H, H-4, J 8.1; 1.2 Hz), 7.01 (dt, 1H, H-2, J 7.5; 1.2 Hz),
7.18-7.21 (m, 1H, H-3), 7.25-7.26 (m, 1H, H-1), 7.42 (ddd, 1H,
H-10, J 8.0; 7.1; 1.1 Hz), 7.47 (dd, 1H, H-12, J 8.6; 1.1 Hz), 7.66
(ddd, 1H, H-11, J 8.6; 7.1; 1.7 Hz), 8.26 (dd, 1H, H-9, J 8.0;
1.7 Hz). 13C NMR (75 MHz, CDCl3): d 33.5 (C-14a), 34.6 (C-14),
68.8 (C-6), 115.7 (C-7), 115.8 (C-7a), 117.7 (C-4), 118.0 (C-12),
121.7 (C-2), 123.9 (C-8a), 124.9 (C-14b), 125.2 (C-10), 126.2 (C-9),
128.06 and 128.13 (C-1 and C-3), 130.2 (C-6a), 133.4 (C-11), 154.6
(C-4a), 155.8 (C-12a), 164.2 (C-13a), 174.2 (C-8).
General procedure for the synthesis of 6H,8H-chromeno[3,4-
b]xanthen-8-ones 12a–d. The appropriate (E)-20-propargyloxy-2-
styrylchromone 4a–d (0.1 mmol) and 1,2,4-TCB (0.3 mL) were
mixed in a closed glass vessel. The resulting mixture was heated
under MW irradiation at 200 1C for 60 min. After that period,
chloranil (10 mmol, 2.5 mg) was added to the crude mixture and
it was heated under MW irradiation at 80 1C for 30 min. The
resulting mixture was dissolved in CH2Cl2 (5 mL) and purified
using preparative TLC using CH2Cl2 as the eluent.
6H,8H-Chromeno[3,4-b]xanthen-8-one (12a). White solid;
yield 22 mg (75%); m.p. 209–211 1C. 1H NMR (300 MHz, CDCl3):
d 5.23 (s, 2H, H-6), 7.05 (dd, 1H, H-4, J 8.1; 1.2 Hz), 7.13 (dt, 1H,
H-2, J 7.7; 1.2 Hz), 7.35 (ddd, 1H, H-3, J 8.1; 7.7; 1.6 Hz), 7.39
(ddd, 1H, H-10, J 8.0; 7.1; 1.1 Hz), 7.51 (dd, 1H, H-12, J 8.4;
1.1 Hz), 7.74 (ddd, 1H, H-11, J 8.4; 7.1; 1.7 Hz), 7.76 (s, 1H,
H-14), 7.81 (dd, 1H, H-1, J 7.7; 1.6 Hz), 8.12 (s, 1H, H-7), 8.34
(dd, 1H, H-9, J 8.0; 1.7 Hz) ppm. 13C NMR (75 MHz, CDCl3):
d 68.0 (C-6), 110.9 (C-14), 117.9 and 118.0 (C-4 and C-12), 120.7
(C-7a), 121.4 (C-14b), 121.9 (C-8a), 122.5 and 122.6 (C-2 and C-7),
124.1 (C-10), 124.4 (C-1), 126.7 (C-9), 127.6 (C-6a), 131.5 (C-3),
134.9 (C-11), 137.0 (C-14a), 155.6 (C-4a), 156.2 (C-12a), 156.5
(C-13a), 176.6 (C-8) ppm. HRMS (ESI+): m/z [M + H]+ calcd for
C20H13O3: 301.0859; found 301.0864.
11-Methoxy-6H,8H-chromeno[3,4-b]xanthen-8-one (12b). White
solid; yield 27 mg (81%); m.p. 223–225 1C. 1H NMR (500 MHz,
CDCl3): d 3.95 (s, 3H, 11-OCH3), 5.21 (s, 2H, H-6), 6.89 (d, 1H,
H-12, J 2.4 Hz), 6.95 (dd, 1H, H-10, J 8.9; 2.4 Hz), 7.04 (dd, 1H,
H-4, J 8.2; 1.2 Hz), 7.12 (dt, 1H, H-2, J 7.6; 1.2 Hz), 7.34 (ddd, 1H,
H-3, J 8.2; 7.6; 1.6 Hz), 7.71 (s, 1H, H-14), 7.79 (dd, 1H, H-1, J 7.6;
1.6 Hz), 8.09 (s, 1H, H-7), 8.24 (d, 1H, H-9, J 8.9 Hz) ppm. 13C
NMR (125 MHz, CDCl3): d 55.9 (11-OCH3), 68.0 (C-6), 100.3
(C-12), 110.6 (C-14), 113.3 (C-10), 115.8 (C-8a), 118.0 (C-4), 120.8
(C-14b), 121.5 (C-7a), 122.5 and 122.6 (C-2 and C-7), 124.3 (C-1),
127.5 (C-6a), 128.3 (C-9), 131.3 (C-3), 136.5 (C-14a), 155.6 (C-4a),
156.5 (C-13a), 158.1 (C-12a), 165.1 (C-11), 175.7 (C-8) ppm.
HRMS (ESI+): m/z [M + H]+ calcd for C21H15O4: 331.0965; found
331.0971.
9-Methoxy-6H,8H-chromeno[3,4-b]xanthen-8-one (12c). White
solid; yield 27 mg (82%); m.p. 257–258 1C. 1H NMR (500 MHz,
CDCl3): d 4.02 (s, 3H, 9-OCH3), 5.20 (s, 2H, H-6), 6.80 (dd, 1H,
H-10, J 8.3; 0.9 Hz), 7.03 (dd, 1H, H-4, J 8.1; 1.2 Hz), 7.06 (dd,
1H, H-12, J 8.3; 0.9 Hz), 7.10 (dt, 1H, H-2, J 7.5; 1.2 Hz), 7.33
(ddd, 1H, H-3, J 8.1; 7.5; 1.6 Hz), 7.60 (t, 1H, H-11, J 8.3 Hz), 7.66
(s, 1H, H-14), 7.77 (dd, 1H, H-1, J 7.5; 1.6 Hz), 8.06 (s, 1H, H-7) ppm.
13C NMR (75 MHz, CDCl3): d 56.5 (9-OCH3), 68.0 (C-6), 105.5 (C-10),
110.0 and 110.2 (C-12 and C-14), 112.5 (C-8a), 117.9 (C-4), 121.5
(C-14b), 121.9 (C-7a), 122.4 and 122.7 (C-2 and C-7), 124.3 (C-1),
127.5 (C-6a), 131.2 (C-3), 134.8 (C-11), 136.3 (C-14a), 155.3
(C-13a), 155.6 (C-4a), 158.2 (C-12a), 160.7 (C-9), 175.9 (C-8) ppm.
HRMS (ESI+): m/z [M + H]+ calcd for C21H15O4: 331.0965; found
331.0971.
9,11-Dimethoxy-6H,8H-chromeno[3,4-b]xanthen-8-one (12d). White
solid; yield 28 mg (78%); m.p. 249–250 1C. 1H NMR (500 MHz,
CDCl3): d 3.92 (s, 3H, 11-OCH3), 3.98 (s, 3H, 9-OCH3), 5.20 (s, 2H,
H-6), 6.34 (d, 1H, H-10, J 2.3 Hz), 6.50 (d, 1H, H-12, J 2.3 Hz), 7.03
(dd, 1H, H-4, J 8.2; 1.2 Hz), 7.10 (dt, 1H, H-2, J 7.5; 1.2 Hz), 7.32
(ddd, 1H, H-3, J 8.2; 7.5; 1.6 Hz), 7.61 (s, 1H, H-14), 7.76 (dd, 1H,
H-1, J 7.5; 1.6 Hz), 8.04 (s, 1H, H-7) ppm. 13C NMR (75 MHz,
CDCl3): d 55.8 (11-OCH3), 56.4 (9-OCH3), 68.0 (C-6), 92.8 (C-12),
95.2 (C-10), 107.3 (C-8a), 109.9 (C-14), 117.9 (C-4), 121.6 (C-14b),
122.0 (C-7a), 122.4 and 122.7 (C-2 and C-7), 124.2 (C-1), 127.4
(C-6a), 131.1 (C-3), 135.8 (C-14a), 155.2 (C-13a), 155.5 (C-4a),
159.8 (C-12a), 162.0 (C-9), 164.9 (C-11), 174.8 (C-8) ppm. HRMS
(ESI+): m/z [M + H]+ calcd for C22H17O5: 361.1071; found 361.1076.
General procedure for the synthesis of 2-(6H-benzo[c]chromen-
8-yl)-4H-chromen-4-ones 13a–d. The appropriate chromone
derivative 7a–d (0.1 mmol) and 1,2,4-TCB (0.3 mL) were mixed
in a closed glass vessel. The resulting mixture was heated under
MW irradiation at 200 1C for 60 min. After that period, chloranil
(10 mmol, 2.5 mg) was added to the crude mixture and it was
heated under MW irradiation at 80 1C for 30 min. After that
period, the crude was dissolved in CH2Cl2 (5 mL) and purified
using preparative TLC using hexane/EtOAc (9:7) as the eluent.
2-(6H-Benzo[c]chromen-8-yl)-4H-chromen-4-one (13a). White
solid; yield 28 mg (85%); m.p. 229–232 1C. 1H NMR (300 MHz,
CDCl3): d 5.23 (s, 2H, H-100), 6.85 (s, 1H, H-3), 7.04 (dd, 1H, H-20,
J 8.1; 1.2 Hz), 7.11 (dt, 1H, H-40, J 7.6; 1.2 Hz), 7.32 (ddd, 1H,
H-30, J 8.1; 7.6; 1.6 Hz), 7.44 (ddd, 1H, H-6, J 8.0; 7.1; 1.0 Hz),
7.60 (dd, 1H, H-8, J 8.7; 1.0 Hz), 7.69–7.75 (m, 2H, H-7, H-90),
7.79 (dd, 1H, H-50, J 7.6; 1.6 Hz), 7.84 (d, 1H, H-60, J 8.2 Hz), 7.94
(dd, 1H, H-70, J 8.2; 2.0 Hz), 8.25 (dd, 1H, H-5, J 8.0; 1.7 Hz) ppm.
13C NMR (75 MHz, CDCl3): d 68.3 (C-100), 107.4 (C-3), 117.7
(C-20), 118.1 (C-8), 121.9 (C-50a), 122.5; 122.6 and 122.7 (C-40,
C-60 and C-90), 123.8 (C-50), 124.0 (C-4a), 125.3 (C-6), 125.8 (C-5),
126.4 (C-70), 130.716 and 130.724 (C-30 and C-80), 132.0 (C-90a),
133.5 (C-50b), 133.9 (C-7), 155.2 (C-10a), 156.2 (C-8a), 162.8 (C-2),
178.4 (C-4) ppm. HRMS (ESI+): m/z [M + H]+ calcd for C22H15O3:
327.1016; found 327.1019.
2-(6H-Benzo[c]chromen-8-yl)-7-methoxy-4H-chromen-4-one (13b).
White solid; yield 29 mg (81%); m.p. 184–187 1C. 1H NMR
(300 MHz, CDCl3): d 3.95 (s, 3H, 7-OCH3), 5.22 (s, 2H, H-100),
6.78 (s, 1H, H-3), 6.99–7.05 (m, 3H, H-6, H-8, H-20), 7.10 (dt, 1H,
H-40, J 7.6; 1.3 Hz), 7.31 (ddd, 1H, H-30, J 8.1; 7.6; 1.6 Hz), 7.71 (d,
1H, H-90, J 1.7 Hz), 7.78 (dd, 1H, H-50, J 7.6; 1.6 Hz), 7.82 (d, 1H,
H-60, J 8.2 Hz), 7.91 (dd, 1H, H-70, J 8.2; 1.7 Hz), 8.14 (d, 1H, H-5,
J 9.5 Hz) ppm. 13C NMR (75 MHz, CDCl3): d 55.9 (7-OCH3),
68.3 (C-100), 100.4 (C-8), 107.3 (C-3), 114.5 (C-6), 117.7 (C-20), 117.9
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123.8 (C-50), 126.3 (C-70), 127.1 (C-5), 130.6 (C-30), 130.8 (C-80),
132.0 (C-90a), 133.3 (C-50b), 155.1 (C-10a), 158.0 (C-8a), 162.3 (C-2),
164.2 (C-7), 177.8 (C-4) ppm. HRMS (ESI+): m/z [M + H]+ calcd for
C23H17O4: 357.1121; found 357.1127.
2-(6H-Benzo[c]chromen-8-yl)-5-methoxy-4H-chromen-4-one (13c).
White solid; yield 30 mg (85%); m.p. 227–229 1C. 1H NMR
(300 MHz, CDCl3): d 4.00 (s, 3H, 5-OCH3), 5.20 (s, 2H, H-100),
6.75 (s, 1H, H-3), 6.83 (dd, 1H, H-6, J 8.4; 0.9 Hz), 7.02 (dd, 1H,
H-20, J 8.1; 1.2 Hz), 7.09 (dt, 1H, H-40, J 7.5; 1.2 Hz), 7.15 (dd, 1H,
H-8, J 8.4; 0.9 Hz), 7.27–7.33 (m, 1H, H-30), 7.58 (t, 1H, H-7,
J 8.4 Hz), 7.68 (d, 1H, H-90, J 1.9 Hz), 7.75–7.81 (m, 1H, H-50), 7.79
(d, 1H, H-60, J 8.1 Hz), 7.88 (dd, 1H, H-70, J 8.1; 1.9 Hz) ppm.
13C NMR (75 MHz, CDCl3): d 56.5 (5-OCH3), 68.3 (C-100), 106.5
(C-6), 108.9 (C-3), 110.1 (C-8), 114.6 (C-4a), 117.6 (C-20), 122.0
(C-50a), 122.3; 122.4 and 122.5 (C-40, C-60 and C-90), 123.7 (C-50),
126.2 (C-70), 130.4 (C-80), 130.6 (C-30), 131.9 (C-90a), 133.2 (C-50b),
133.8 (C-7), 155.1 (C-10a), 158.2 (C-8a), 159.8 (C-5), 160.5 (C-2),
178.3 (C-4) ppm. HRMS (ESI+): m/z [M + H]+ calcd for C23H17O4:
357.1121; found 357.1123.
2-(6H-Benzo[c]chromen-8-yl)-5,7-dimethoxy-4H-chromen-4-one
(13d). White solid; yield 30 mg (78%); m.p. 178–181 1C. 1H NMR
(300 MHz, CDCl3): d 3.93 (s, 3H, 7-OCH3), 3.96 (s, 3H, 5-OCH3),
5.19 (s, 2H, H-100), 6.38 (d, 1H, H-6, J 2.3 Hz), 6.59 (d, 1H, H-8,
J 2.3 Hz), 6.69 (s, 1H, H-3), 7.02 (dd, 1H, H-20, J 8.1; 1.2 Hz), 7.09
(dt, 1H, H-40, J 7.7; 1.2 Hz), 7.27–7.33 (m, 1H, H-30), 7.66 (d, 1H,
H-90, J 1.6 Hz), 7.76 (dd, 1H, H-50, J 7.7; 1.7 Hz), 7.78 (d, 1H, H-60,
J 8.2 Hz), 7.86 (dd, 1H, H-70, J 8.2; 1.6 Hz) ppm. 13C NMR
(75 MHz, CDCl3): d 55.8 (7-OCH3), 56.4 (5-OCH3), 68.3 (C-100),
92.8 (C-8), 96.2 (C-6), 108.9 (C-3), 109.3 (C-4a), 117.6 (C-20), 122.0
(C-50a), 122.2 (C-90), 122.4 and 122.5 (C-40 and C-60), 123.7 (C-50),
126.0 (C-70), 130.5 and 130.6 (C-80 and C-30), 131.9 (C-90a), 133.0
(C-50b), 155.1 (C-10a), 159.8 and 160.0 (C-2 and C-8a), 160.9 (C-5),
164.1 (C-7), 177.5 (C-4) ppm. HRMS (ESI+): m/z [M + H]+ calcd for
C24H19O5: 387.1227; found 387.1233.
Synthesis of (E)-2-(2-allyloxystyryl)-4H-chromen-4-one (15).
To a mixture of sodium (110 mg, 5 mmol) in ethanol (5 mL)
was added the 2-methylchromone 2a (200 mg, 1.25 mmol) and the
O-allyloxybenzaldehyde 14 (253 mg, 1.56 mmol). The resulting
mixture was stirred at room temperature for 2 h. After that period,
the mixture was poured into ice (20 g) and water (30 mL) and the
pH was adjusted to 4 with dilute HCl (10%). The precipitate was
removed via filtration, taken in CH2Cl2 and purified using silica gel
column chromatography using CH2Cl2 as the eluent. Yellow solid;
yield 346 mg (91%); m.p. 109–111 1C. 1H NMR (500 MHz, CDCl3):
d 4.68 (dt, 2H, H-100, J 5.1; 1.6 Hz), 5.37 (dq, 1H, H-300, J 10.6; 1.6 Hz),
5.50 (dq, 1H, H-300, J 17.2; 1.6 Hz), 6.14 (ddt, 1H, H-200, J 17.2; 10.5;
5.1 Hz), 6.34 (s, 1H, H-3), 6.93 (d, 1H, H-a, J 16.2 Hz), 6.95 (dd, 1H,
H-30, J 8.3; 1.0 Hz), 7.02 (dt, 1H, H-50, J 7.5; 1.0 Hz), 7.34 (ddd, 1H,
H-40, J 8.3; 7.5; 1.7 Hz), 7.39 (ddd, 1H, H-6, J 8.0; 7.1; 1.1 Hz), 7.55
(dd, 1H, H-8, J 8.5; 1.1 Hz), 7.60 (dd, 1H, H-60, J 7.5; 1.7 Hz), 7.68
(ddd, 1H, H-7, J 8.5; 7.1; 1.6 Hz), 7.97 (d, 1H, H-b, J 16.2 Hz), 8.20
(dd, 1H, H-5, J 8.0; 1.6 Hz). 13C NMR (75 MHz, CDCl3): d 69.2 (C-100),
110.3 (C-3), 112.6 (C-30), 117.8 and 117.9 (C-8 and C-300), 120.9
(C-a), 121.1 (C-50), 124.2 and 124.3 (C-10 and C-4a), 124.9 (C-6),
125.6 (C-5), 128.4 (C-60), 131.0 (C-40), 132.4 (C-b), 132.9 (C-200),
133.6 (C-7), 156.1 (C-20), 157.1 (C-8a), 162.5 (C-2), 178.6 (C-4).
Synthesis of (E)-2-(3-allyl-2-hydroxystyryl)-4H-chromen-4-one
(16). The chromone derivative 15 (30 mg, 0.1 mmol) and 1,2,4-
TCB (0.3 mL) were mixed in a closed glass vessel. The resulting
mixture was heated under MW irradiation at 200 1C for 60 min.
After that period, the crude mixture was dissolved in CH2Cl2
(5 mL) and purified via preparative TLC using hexane/EtOAc
(9 : 7) as the eluent. Yellow solid; yield 6 mg (21%); m.p. 185–187 1C.
1H NMR (500 MHz, CDCl3): d 3.50 (dt, 1H, H-100, J 6.3; 1.7 Hz),
5.28-5.32 (m, 2H, H-300), 5.86 (s, 1H, 20-OH), 6.06 (ddt, 1H, H-200,
J 15.9; 10.7; 6.2 Hz), 6.34 (s, 1H, H-3), 6.92 (d, 1H, H-a,
J 16.1 Hz), 6.94–6.97 (t, 1H, H-50, J 7.8 Hz), 7.14 (dd, 1H, H-40,
J 7.8; 1.6 Hz), 7.39 (ddd, 1H, H-6, J 8.0; 7.3; 1.0 Hz), 7.49 (dd, 1H,
H-60, J 7.8; 1.6 Hz), 7.53 (dd, 1H, H-8, J 8.4; 1.0 Hz), 7.67 (ddd,
1H, H-7; J 8.4; 7.3; 1.7 Hz), 7.93 (d, 1H, H-b, J 16.1 Hz), 8.20 (dd,
1H, H-5, J 8.0; 1.7 Hz). 13C NMR (75 MHz, CDCl3): d 35.9 (C-100),
110.3 (C-3), 117.8 and 117.9 (C-8 and C-300), 121.07 and 121.10
(C-50 and C-a), 123.1 (C-10), 124.1 (C-4a), 124.9 (C-6), 125.4
(C-30), 125.6 (C-5), 127.1 (C-60), 132.0 (C-40), 132.4 (C-b),
133.7 (C-7), 135.8 (C-200), 153.7 (C-20), 156.0 (C-8a), 162.4 (C-2),
178.6 (C-4).
Synthesis of (1E,3E)-2-[4-(2-allyloxyphenyl)buta-1,3-dien-1-
yl]-4H-chromen-4-one (17). A solution of BBr3 in CH2Cl2 1M
(1.64 mL) was added to a solution of chromone derivative 6a
(200 mg, 0.657 mmol) in CH2Cl2 (5 mL) under a nitrogen
atmosphere. The resulting mixture was stirred at room tem-
perature for 2 h. After that period, the mixture was poured into
ice (5 g) and water (15 mL) and the slurry was stirred until the
formation of a precipitate was achieved. The precipitate was
removed via filtration and washed with water (100 mL) and
ethyl ether (50 mL). To a stirring mixture of the precipitate in
acetone (30 mL) was added K2CO3 (136 mg, 1.5 equiv.) and allyl
bromide (0.2 mL; 3 equiv.). The resulting mixture was stirred at
reflux for 4 h. After that period, the mixture was poured into ice
(5 g) and water (15 mL) and the pH was adjusted to 4 with dilute
HCl (10%). The aqueous layer was extracted with CH2Cl2 (3 
50 mL), dried over anhydrous Na2SO4 and the solvent evapo-
rated to dryness. The residue was purified via preparative TLC
using CH2Cl2/EtOAc (5 : 1) as the eluent. Yellow solid; yield
169 mg (78%); m.p. 120–122 1C. 1H NMR (500 MHz, CDCl3):
d 4.63 (dt, 2H, H-100, J 5.2; 1.5 Hz), 5.35 (dq, 1H, H-300, J 10.5; 1.5
Hz), 5.47 (dq, 1H, H-300, J 17.3; 1.5 Hz), 6.13 (ddt, 1H, H-200, J
17.3; 10.5; 5.2 Hz), 6.25 (s, 1H, H-3), 6.35 (d, 1H, H-a, J 15.2 Hz),
6.91 (dd, 1H, H-30, J 8.4; 1.0 Hz), 6.98 (dt, 1H, H-50, J 7.6; 1.0 Hz),
7.03 (ddd, 1H, H-g, J 15.7; 11.0; 0.7 Hz), 7.27–7.30 (m, 1H, H-40),
7.34 (d, 1H, H-d, J 15.7 Hz), 7.38 (ddd, 1H, H-6, J 7.9; 7.1;
1.1 Hz), 7.47 (ddd, 1H, H-b, J 15.2; 11.0; 0.8 Hz), 7.51 (dd, 1H,
H-8, J 8.4; 1.1 Hz), 7.55 (dd, 1H, H-60, J 7.6; 1.7 Hz), 7.67 (ddd,
1H, H-7; J 8.4; 7.1; 1.7 Hz), 8.19 (dd, 1H, H-5, J 7.9; 1.7 Hz).
13C NMR (75 MHz, CDCl3): d 69.2 (C-100), 110.1 (C-3), 112.5
(C-30), 117.8 and 117.9 (C-8 and C-300), 121.0 (C-50), 122.9
(C-a), 124.2 (C-4a), 124.9 (C-6), 125.5 (C-10), 125.6 (C-5), 127.2
(C-60), 127.6 (C-g), 130.0 (C-40), 133.1 (C-200), 133.6 (C-7),
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Eur. J. Org. Chem., 1999, 135.
10 D. C. G. A. Pinto, A. M. S. Silva, C. M. Brito, A. Sandulache,
J. R. Carrillo, P. Prieto, A. Dı́az-Ortiz, A. de la Hoz and
J. A. S. Cavaleiro, Eur. J. Org. Chem., 2005, 2973.
11 D. T. Patoilo, A. M. S. Silva, D. C. G. A. Pinto, A. C. Tomé and
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